Vaccitech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vaccitech's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16580% to $44,703,000. The net income raised on $5,342,000 and profit margin reached 12%. Total operating expenses were $47,504,000.

Profit Margin

Vaccitech plc (NASDAQ:VACC): Profit margin
2019 6.84M -20.72M -302.84%
2020 4.82M -17.93M -372.05%
2021 268K -51.11M -19071.64%
2022 44.70M 5.34M 11.95%

VACC Income Statement (2019 – 2022)

2022 2021 2020 2019
Revenue
Revenue
44.70M268K4.82M6.84M
Cost of revenue
42.35M20.37M14.38M29.84M
Gross profit
2.35M-20.10M-9.56M-22.99M
Operating exp.
Research and development
41.11M16.37M11.10M29.84M
Selling and marketing
0000
Total operating expenses
47.50M41.48M21.58M391.95K
Operating income
-3.45M-45.22M-20.04M-22.68M
Other income (expenses), net
4.30M-5.91M2.20M-9.09K
Income before tax
850K-51.14M-17.83M-22.69M
Income tax expense
-4.47M-28K95.01K-1.96M
Net income
5.34M-51.11M-17.93M-20.72M
Earnings per share
Basic EPS
0.14-1.97-2.27-883.28
Diluted EPS
0.14-1.97-2.27-883.28
Data sourceData source